Viewing Study NCT00402766


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-03-05 @ 11:38 AM
Study NCT ID: NCT00402766
Status: COMPLETED
Last Update Posted: 2015-11-18
First Post: 2006-11-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Sponsor: M.D. Anderson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2005-0288
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View